Other
Weight Gain
3
Pipeline Programs↗
3
Active Trials↗
6
Companies Involved↗
Weight Gain is an early-stage landscape with 3 programs across 6 companies. The most active players are Gilead, GSK, Corcept Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
34
clinical trials
Completed23 · 68%
Terminated6 · 18%
Recruiting2 · 6%
Not yet recruiting1 · 3%
Withdrawn1 · 3%
Unknown status1 · 3%
Clinical Trials
Trial Activity
34 trials
Early Metabolic Effects of Antiretroviral Drugs in Healthy Volunteers: A Phase 2 Randomized Study
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT05652478·120 enrolled
LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression
Completed·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 4·NCT01601002·19 enrolled
L-Carnitine Supplementation, Rate of Weight Gain and EED in Children With SAM
Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·N/A·NCT05083637·98 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)